From Bioinformatics Analysis to Recombinant Expression: Advancing Public Health with Taenia solium Proteins
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26199585 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Juana Muñoz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Sciences, Pontificia Universidad Javeriana, Bogotá, D.C. 110231, Colombia. Hauptthemen laut MEDLINE: Taenia solium, Computational Biology, Antigens, Helminth, Helminth Proteins. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Salud, National Institute of Health of Colombia, Pontificia Universidad Javeriana.
Abstract (Originalsprache)
Taeniasis and neurocysticercosis (NCC), caused by Taenia solium, are significant public health concerns recognised by the World Health Organization (WHO) in developing countries across the Americas, Asia, and Africa. Taeniasis occurs in humans after consuming undercooked pork containing the larval stage (Cysticerci), which matures into the adult reproductive form in the intestine, releasing eggs through faeces. Accidental ingestion of these eggs by humans is the primary cause of NCC, a principal contributor to acquired epilepsy in endemic regions. Interrupting this transmission cycle is crucial to reducing the incidence of human NCC and porcine cysticercosis, thereby underscoring the need for accurate diagnosis and timely treatment of taeniasis. Current diagnostic tests for taeniasis, including microscopy, serology, copro-DNA, and coproantigen assays, exhibit variability in sensitivity, reproducibility, cross-reactivity, and accessibility. To overcome these limitations, bioinformatics tools were integrated with recombinant DNA technology to identify protein sequences with immunological potential. These sequences were evaluated in silico and used to construct an expression system. Subsequently, the antigens were expressed in a eukaryotic system, yielding two purified recombinant protein variants of 21 and 30 kDa. Their purification validated via Western blotting of the molecular tag, paves the way for the development of a direct immunological assay for the specific detection of Taenia solium carriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Sciences, Pontificia Universidad Javeriana, Bogotá, D.C. 110231, Colombia.
- Parasitology Group, Directorate of Public Health Research, Instituto Nacional de Salud, Bogotá, D.C. 111321, Colombia.
- Emerging, Re-Emerging and Neglected Diseases Group, Sub-Directorate of Communicable Diseases, Ministry of Health and Social Protection, Bogotá, D.C. 110311, Colombia.
ORCID-Profile: Juana Muñoz, María Camila Jurado Guacaneme, Clemencia Ovalle-Bracho, Julián Trujillo Trujillo, Sofía Duque-Beltrán, Carlos Franco-Muñoz
Förderung
- Instituto Nacional de Salud
- National Institute of Health of Colombia
- Pontificia Universidad Javeriana
Zitieren
APA
Muñoz, J., Guacaneme, M. C. J., Ovalle-Bracho, C., Trujillo, J. T., Duque-Beltrán, S., Arévalo, A., & Franco-Muñoz, C. (2025). From Bioinformatics Analysis to Recombinant Expression: Advancing Public Health with Taenia solium Proteins. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199585
Vancouver
Muñoz J, Guacaneme MCJ, Ovalle-Bracho C, Trujillo JT, Duque-Beltrán S, Arévalo A, et al. From Bioinformatics Analysis to Recombinant Expression: Advancing Public Health with Taenia solium Proteins. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199585
BibTeX
@article{Muoz2025,
author = {Muñoz, Juana and Guacaneme, María Camila Jurado and Ovalle-Bracho, Clemencia and Trujillo, Julián Trujillo and Duque-Beltrán, Sofía and Arévalo, Adriana and Franco-Muñoz, Carlos},
title = {From Bioinformatics Analysis to Recombinant Expression: Advancing Public Health with Taenia solium Proteins},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26199585}
}
EUVIMED